Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
IPO Year:
Exchange: NASDAQ
Website: trupanion.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/23/2025 | $57.00 | Neutral → Overweight | Piper Sandler |
| 7/19/2024 | Outperform | William Blair | |
| 5/16/2024 | $35.00 → $49.00 | Neutral → Buy | BofA Securities |
| 5/8/2023 | $72.00 → $32.00 | Buy → Neutral | BofA Securities |
| 9/21/2022 | $77.00 | Buy | Jefferies |
| 8/4/2022 | $80.00 → $69.00 | Overweight → Neutral | Piper Sandler |
| 2/24/2022 | $129.00 → $118.00 | Neutral → Buy | B of A Securities |
| 12/8/2021 | $126.00 → $183.00 | Overweight | Piper Sandler |
| 11/8/2021 | $112.00 → $129.00 | Buy → Neutral | BofA Securities |
| 10/18/2021 | $112.00 | Buy | BofA Securities |
SEATTLE, May 05, 2025 (GLOBE NEWSWIRE) -- Trupanion (NASDAQ:TRUP), the leading provider of medical insurance for dogs and cats, will host an upcoming webinar focused on the evolving state of bird flu (H5N1) and its impact on pets, pet parents, and the veterinary community. The complimentary one-hour RACE®-Approved CE webinar "Bird Flu: What We Know Now" will be available on-demand on petpublichealth.org/h5n1-update/ on Thursday, May 8th, at 11:00 AM PT / 2:00 PM ET. Hosted by Trupanion's Chief Veterinary/Product Officer, Dr. Steve Weinrauch, BVMS, MRCVS, the webinar features a panel of leading animal health experts, including: Gail Golab, PhD, DVM, MANZCVS (Animal Welfare), DACAW: Assoc
SEATTLE, May 01, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter ended March 31, 2025. "Q1 was a strong start to the year, with performance ahead of plan across key metrics," said Margi Tooth, Chief Executive Officer and President of Trupanion. "We saw early momentum in both retention and pet acquisition, and with expanded margins in our subscription business, we're well-positioned to continue to invest in growth." First Quarter 2025 Financial and Business Highlights Total revenue was $342.0 million, an increase of 12% compared to the first quarter of 2024.Total e
SEATTLE, April 30, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, has published its 2024 annual shareholder letter from CEO and President, Margi Tooth. The letter is now available on the Company's Investor Relations website here. About Trupanion: Trupanion is a leader in medical insurance for cats and dogs throughout the United States, Canada, certain countries in Continental Europe, and Australia with over 1,000,000 pets currently enrolled. For over two decades, Trupanion has given pet owners peace of mind so they can focus on their pet's recovery, not financial stress. Trupanion is committed to providing pet parents with the hig
SEATTLE, April 17, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2025 first quarter after the market closes on Thursday, May 1, 2025. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast discussing results, guidance and management observations will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. A slide presentation will also be available on the site. Participants can acce
SEATTLE, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, announced today that Fawwad Qureshi, Chief Financial Officer, will present at the 46th Annual Raymond James Institutional Investor Conference on Monday, March 3, 2025, at 8:05 a.m. ET and will participate in meetings with investors throughout the day. The presentation will be webcast live and can be accessed on Trupanion's Investor Relations website at http://investors.trupanion.com. About Trupanion: Trupanion is a leader in medical insurance for cats and dogs throughout the United States, Canada, certain countries in Continental Europe, and Australia with over 1,00
SEATTLE, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the fourth quarter and full year ended December 31, 2024. "2024 was a milestone year for Trupanion. Strong execution drove 20% subscription revenue growth, the doubling of our subscription margin in Q4 from its quarterly low in 2023, and a record $39 million in free cash flow," said Margi Tooth, Chief Executive Officer and President of Trupanion. "As we look to 2025, our focus remains on sustainable, measured growth while enhancing the member experience and improving retention." Fourth Quarter 2024 Financial and
SEATTLE, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2024 fourth quarter and full year after the market closes on Wednesday, February 19, 2025. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast discussing results, guidance and management observations will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. A slide presentation will also be available on the site.
SEATTLE, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leading provider of medical insurance for cats and dogs in North America, was honored today by Built In and its 2025 Best Places To Work Awards. Trupanion earned a spot on Built In's Best Places to Work in Seattle and 100 Best Large Places to Work in Seattle. This achievement marks the 6th consecutive year Trupanion has been recognized among Seattle's top workplaces by Built In. "It is a delight to see Trupanion named one of the Best Places to Work in Seattle for the 6th consecutive year," says Trupanion CEO, Margi Tooth. "At Trupanion, we are dedicated to fostering a work environment that empowers them to gro
NEW YORK, Dec. 17, 2024 /PRNewswire/ -- URvet Care, a trusted provider of exceptional veterinary care, is proud to announce its collaboration with Trupanion, a leading provider of pet medical insurance for cats and dogs. This collaboration allows URvet Care to help pet parents through Trupanion's innovative Vet Direct Pay solution. Trupanion is the only pet insurer in North America capable of paying their portion of a client's invoice directly to the treating hospital at the time of checkout – in less than a minute, on average. With this partnership, URvet Care joins more than
SEATTLE, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leading provider of medical insurance for cats and dogs in North America, announced today the receipt of six 2024 VIBE Awards related to employee benefits. Trupanion was named a top employer in six out of seven categories, gaining recognition in Financial & Retirement, Health & Wellness Benefits, Parental Benefits, Work Flexibility, Professional Development Benefits, and Vacation & Time Off Benefits. "Trupanion is made up of passionate people who care deeply about helping cats and dogs in their time of need. We extend this philosophy to our team members, striving to offer a competitive benefits package t
10-Q - TRUPANION, INC. (0001371285) (Filer)
8-K - TRUPANION, INC. (0001371285) (Filer)
DEFA14A - TRUPANION, INC. (0001371285) (Filer)
DEFA14A - TRUPANION, INC. (0001371285) (Filer)
DEF 14A - TRUPANION, INC. (0001371285) (Filer)
144 - TRUPANION, INC. (0001371285) (Subject)
10-K - TRUPANION, INC. (0001371285) (Filer)
8-K - TRUPANION, INC. (0001371285) (Filer)
SCHEDULE 13G/A - TRUPANION, INC. (0001371285) (Subject)
144 - TRUPANION, INC. (0001371285) (Subject)
4/A - TRUPANION, INC. (0001371285) (Issuer)
4 - TRUPANION, INC. (0001371285) (Issuer)
Boehringer Ingelheim, Mars Science & Diagnostics and leading pet, public health and animal health authorities to join Advisory Board Collaboration to address emerging pet and public health threats to protect pets and peopleEarly detection potential has global pet and public health benefits SEATTLE, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leading provider of medical insurance for cats and dogs in North America, in partnership with the Centers for Disease Control and Prevention (CDC), and leading pet industry partners, today announced the formation of a collaborative Advisory Board to launch a Pet & Public Health Early Warning & Detection System. The Advisory B
SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced that its Board of Directors has unanimously approved the appointment of Margi Tooth to Chief Executive Officer, effective August 1, 2024. Tooth's appointment to CEO marks the culmination of a multi-year, board-led process. Tooth will also continue as President and hold the dual titles of CEO and President. Additionally, Tooth is anticipated to be appointed to Trupanion's Board of Directors during its July meeting. Trupanion's founder and outgoing CEO Darryl Rawlings will continue to serve in the role of Chair of the Board, in which capacity he
A global entrepreneur with decades of experience growing insurance businesses worldwide, including pet insurance brands in Australia and South AfricaEnthoven associated with Tarmac DLTFM LTD., holder of 8.6% of Trupanion outstanding shares SEATTLE, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP) has appointed Richard Enthoven, Director at PetSure Australia and Hollard Holdings Australia, as an independent director to the Company's Board of Directors, effective today. Tarmac DLTFM LTD. ("Tarmac"), an Enthoven family investment entity, purchased shares of Trupanion in the open market between July and October of 2023, amounting to approximately 8.6% of Trupanion's outsta
SEATTLE, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leading provider of pet medical insurance for cats and dogs, announced today the appointment of Fawwad Qureshi as Chief Finance Officer. Mr. Qureshi will officially join Trupanion on September 25, 2023. Mr. Qureshi joins Trupanion with over 20 years of senior-level financial experience, successfully steering growth in revenue and profitability for publicly-traded, global growth companies. Notably, during his most recent tenure at Expedia Group as Senior Vice President of Finance and CFO of Brands, Qureshi had full P&L and commercial responsibility for its over $9 billion portfolio of world-class consumer brand
SEATTLE, July 05, 2023 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP) announced that Max Brodén, Chief Financial Officer of Aflac Incorporated, has been appointed to serve as an independent director effective July 4, 2023. This appointment expands the Board to nine directors, eight of whom are independent. "We're excited to welcome Max as the newest independent member of our Board," said Darryl Rawlings, Founder, CEO and Chair of the Board. "Max's global financial knowledge and expertise in both the insurance and investment industries, including as CFO for the largest publicly traded supplemental health insurance company, will be extremely valuable to Trupanion." "Max is a natural lea
New Independent Directors Bring Significant Experience with Global Growth Brands SEATTLE, April 27, 2023 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP) announced today the appointment of Paulette Dodson, former General Counsel and Corporate Secretary at Alight, Inc., PetSmart Inc., and Sara Lee Corporation, and Elizabeth "Betsy" McLaughlin, former Chief Executive Officer of Hot Topic, to the Company's Board of Directors. "We're pleased to welcome Paulette and Betsy to our Board," said Darryl Rawlings, Founder, CEO and Chair of the Board. "They bring significant experience driving strategic growth for global consumer brands to Trupanion and are passionate about pets and
SEATTLE, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP) announced today that Darryl Rawlings, Founder & Chief Executive Officer, will assume the additional role of Chair of the Board, effective immediately. Murray Low, PhD, the prior Chair of the Board, will assume the role of Lead Independent Director. Today's announcement is in alignment with the Company's long-term succession plans and Mr. Rawlings's intention to support a smooth CEO succession in 2025 and, if amenable to shareholders, to serve as Chair of the Board until 2035. "I look forward to continuing to actively support Trupanion in my new role as Lead Independent Director," said Dr. Low. "The Board and I are co
4 - TRUPANION, INC. (0001371285) (Issuer)
4 - TRUPANION, INC. (0001371285) (Issuer)
4 - TRUPANION, INC. (0001371285) (Issuer)
4 - TRUPANION, INC. (0001371285) (Issuer)
4 - TRUPANION, INC. (0001371285) (Issuer)
4 - TRUPANION, INC. (0001371285) (Issuer)
4 - TRUPANION, INC. (0001371285) (Issuer)
4 - TRUPANION, INC. (0001371285) (Issuer)
4 - TRUPANION, INC. (0001371285) (Issuer)
4 - TRUPANION, INC. (0001371285) (Issuer)
SEATTLE, May 01, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter ended March 31, 2025. "Q1 was a strong start to the year, with performance ahead of plan across key metrics," said Margi Tooth, Chief Executive Officer and President of Trupanion. "We saw early momentum in both retention and pet acquisition, and with expanded margins in our subscription business, we're well-positioned to continue to invest in growth." First Quarter 2025 Financial and Business Highlights Total revenue was $342.0 million, an increase of 12% compared to the first quarter of 2024.Total e
SEATTLE, April 17, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2025 first quarter after the market closes on Thursday, May 1, 2025. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast discussing results, guidance and management observations will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. A slide presentation will also be available on the site. Participants can acce
SEATTLE, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the fourth quarter and full year ended December 31, 2024. "2024 was a milestone year for Trupanion. Strong execution drove 20% subscription revenue growth, the doubling of our subscription margin in Q4 from its quarterly low in 2023, and a record $39 million in free cash flow," said Margi Tooth, Chief Executive Officer and President of Trupanion. "As we look to 2025, our focus remains on sustainable, measured growth while enhancing the member experience and improving retention." Fourth Quarter 2024 Financial and
SEATTLE, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2024 fourth quarter and full year after the market closes on Wednesday, February 19, 2025. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast discussing results, guidance and management observations will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. A slide presentation will also be available on the site.
SEATTLE, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the third quarter ended September 30, 2024. "Q3 was a very strong financial quarter for the company, combining consistent revenue growth with a 66% year-over-year increase in subscription discretionary profit," said Margi Tooth, Chief Executive Officer and President of Trupanion. "This outperformance was driven by aligning the cost of veterinary care with member pricing, resulting in the achievement of our target value proposition of 71%. Trupanion is solving a bigger problem today than ever before, and after generat
SEATTLE, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2024 third quarter after the market closes on Wednesday, October 30, 2024. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast (including a slide presentation) discussing results, guidance and management observations will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. Participants can access the conferen
SEATTLE, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leading provider of medical insurance for cats and dogs, today announced financial results for the second quarter ended June 30, 2024. "Q2 was a strong quarter, benefitting from consistent revenue growth and margin expansion," said Margi Tooth, President and Chief Executive Officer of Trupanion. "We were able to once again deliver consistent subscription revenue growth while generating free cash flow of $24 million over the past 12 months. Discretionary profit from our core subscription business increased 63% in the quarter, and we look forward to gradually deploying more capital at high estimated internal rates
SEATTLE, July 18, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leader in medical insurance for cats and dogs, announced today it will report financial results for its 2024 second quarter after the market closes on Thursday, August 8, 2024. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast, to include a slide presentation, will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. Participants can access the conference call by dialing 1-877-300-8521 (United States) or 1-412-3
SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter ended March 31, 2024. "It was a solid start to the year, with performance across our key financial metrics as expected," said Margi Tooth, President of Trupanion. "Subscription revenue increased by 22% year-over-year. Moreover, discretionary profit from our core subscription business increased 55% while acquisition spend decreased 23% year-over-year. We continue to prioritize cash flow generation with the intention of gradually increasing our spending on growth as our margins expand." First Quarter
SEATTLE, April 19, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leader in medical insurance for cats and dogs, announced today it will report financial results for its 2024 first quarter after the market closes on Thursday, May 2, 2024. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast, to include a slide presentation, will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. Participants can access the conference call by dialing 1-877-300-8521 (United States) or 1-412-317-
SC 13G/A - TRUPANION, INC. (0001371285) (Subject)
SC 13G/A - TRUPANION, INC. (0001371285) (Subject)
SC 13G/A - TRUPANION, INC. (0001371285) (Subject)
SC 13G - TRUPANION, INC. (0001371285) (Subject)
SC 13G/A - TRUPANION, INC. (0001371285) (Subject)
SC 13G - TRUPANION, INC. (0001371285) (Subject)
SC 13G - TRUPANION, INC. (0001371285) (Subject)
SC 13G/A - TRUPANION, INC. (0001371285) (Subject)
SC 13G/A - TRUPANION, INC. (0001371285) (Subject)
SC 13G - TRUPANION, INC. (0001371285) (Subject)
Piper Sandler upgraded Trupanion from Neutral to Overweight and set a new price target of $57.00
William Blair initiated coverage of Trupanion with a rating of Outperform
BofA Securities upgraded Trupanion from Neutral to Buy and set a new price target of $49.00 from $35.00 previously
BofA Securities downgraded Trupanion from Buy to Neutral and set a new price target of $32.00 from $72.00 previously
Jefferies initiated coverage of Trupanion with a rating of Buy and set a new price target of $77.00
Piper Sandler downgraded Trupanion from Overweight to Neutral and set a new price target of $69.00 from $80.00 previously
B of A Securities upgraded Trupanion from Neutral to Buy and set a new price target of $118.00 from $129.00 previously
Piper Sandler reiterated coverage of Trupanion with a rating of Overweight and set a new price target of $183.00 from $126.00 previously
BofA Securities downgraded Trupanion from Buy to Neutral and set a new price target of $129.00 from $112.00 previously
BofA Securities initiated coverage of Trupanion with a rating of Buy and set a new price target of $112.00